Key result
123I-BMIPP effectively assesses myocardial fatty acid metabolism and diagnoses CAD despite limited use outside Japan.
Why the study?
The utility of 123I-BMIPP for non-invasive assessment of myocardial fatty acid metabolism in CAD diagnosis outside of Japan is underrecognized.
123I-BMIPP is a radiotracer for non-invasive assessment of myocardial fatty acid metabolism, with potential utility in CAD diagnosis.
Answers are grounded in this paper and cite their sources.
Supports targeted 123I-BMIPP use in select CAD cases; leaves open broader adoption outside Japan pending prospective data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yuka Otaki (2024) conducted a review in Coronary artery disease. 123I-BMIPP was evaluated. 123I-BMIPP is a valuable radiotracer for the non-invasive assessment of myocardial fatty acid metabolism and diagnosis of coronary artery disease, though its use remains limited outside of Japan.
Synapse has enriched 10 related papers. Consider them for comparative context: